Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
29.21
+3.20 (12.30%)
At close: Aug 8, 2025, 4:00 PM
29.74
+0.53 (1.81%)
After-hours: Aug 8, 2025, 7:59 PM EDT
Heartland Financial USA Market Cap
Quantum BioPharma has a market cap or net worth of $110.60 million as of August 8, 2025. Its market cap has increased by 1,538.56% in one year.
Market Cap
110.60M
Enterprise Value
109.63M
1-Year Change
1,538.56%
Ranking
Category
Stock Price
$29.21
Market Cap Chart
Since May 29, 2018, Quantum BioPharma's market cap has decreased from $121.65M to $110.60M, a decrease of -9.09%. That is a compound annual growth rate of -1.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 110.60M | 1,488.20% |
| Dec 31, 2024 | 6.96M | -80.54% |
| Dec 29, 2023 | 35.78M | 20.93% |
| Dec 30, 2022 | 29.59M | -29.85% |
| Dec 31, 2021 | 42.18M | 40.94% |
| Dec 31, 2020 | 29.93M | -30.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |